Nebraska Ebola Patient Getting Same Experimental Drug As Texas Patient

Ashoka Mukpo is now taking the same medication that Thomas Eric Duncan received.

— -- The American journalist who is being treated for Ebola at a Nebraska hospital is receiving the same experimental treatment as the Liberian patient who was diagnosed with the disease in Texas.

"Every patient is somewhat different, and we believe Brincidofovir is the best choice," Smith said in a statement released today.

The drug is produced by a North Carolina-based biopharmaceutical company and was authorized by the Food and Drug Administration for use in specific, experimental cases.

Mukpo left Monrovia, Liberia on Sunday night and arrived in Omaha on Monday morning. His parents saw him as he was taken off the plane and said at a press conference Monday that they were happy his conditions had not worsened dramatically since leaving Africa.